Allen C Ho Selected Research

pegaptanib (Macugen)

1/2012	Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response.
3/2010	Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors.
3/2009	Streptococcus mitis endophthalmitis presenting as frosted branch angiitis after intravitreal pegaptanib sodium injection.
9/2007	Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allen C Ho Research Topics

Disease

41	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 06/2005
18	Macular Edema 01/2022 - 09/2007
15	Retinal Vein Occlusion 12/2022 - 04/2003
15	Endophthalmitis (Ophthalmia) 01/2022 - 03/2005
12	Retinal Detachment (Retinal Detachments) 10/2022 - 01/2004
9	Retinal Perforations 01/2019 - 01/2004
8	Epiretinal Membrane (Epiretinal Membranes) 01/2022 - 01/2016
8	Hemorrhage 01/2021 - 09/2007
7	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 12/2016
6	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 10/2015
6	Choroidal Neovascularization 01/2017 - 01/2006
5	Vitreous Hemorrhage 01/2021 - 01/2016
4	Proliferative Vitreoretinopathy 01/2022 - 01/2016
4	Retinal Diseases 01/2021 - 05/2012
4	Cataract (Cataracts) 01/2018 - 03/2005
3	Glaucoma 01/2022 - 08/2008
3	Leber Congenital Amaurosis 01/2022 - 01/2019
2	Presbyopia 07/2022 - 06/2022
2	Ciliopathies 01/2021 - 01/2019
2	Choroidal Effusions 01/2021 - 08/2012
2	Retinal Vasculitis 01/2021 - 07/2015
2	Inflammation (Inflammations) 12/2020 - 09/2010
2	Pain (Aches) 05/2020 - 01/2018
2	Central Serous Chorioretinopathy 01/2020 - 06/2015
2	Edema (Dropsy) 01/2020 - 10/2016
2	Intraoperative Complications 01/2019 - 01/2019
2	Burns 01/2018 - 09/2006
2	Retinal Degeneration 10/2016 - 04/2012
2	Low Vision (Subnormal Vision) 05/2016 - 11/2014
2	Ischemia 07/2015 - 08/2014
1	Malignant Hypertension 05/2022
1	Retinitis 05/2022
1	Wounds and Injuries (Trauma) 11/2021
1	Sympathetic Ophthalmia (Sympathetic Uveitis) 11/2021
1	COVID-19 10/2021
1	Neoplasm Metastasis (Metastasis) 05/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2021
1	Retinal Hemorrhage 05/2021
1	Postoperative Hemorrhage 01/2021
1	Vitreous Detachment (Posterior Vitreous Detachment) 09/2020
1	Retinal Artery Occlusion 09/2019
1	vitreous floaters 01/2018
1	Pulmonary Arterial Hypertension 12/2017

Drug/Important Bio-Agent (IBA)

32	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 10/2008
20	Ranibizumab (Lucentis)FDA Link 01/2021 - 03/2010
16	Retinaldehyde (Retinal)IBA 01/2022 - 01/2011
12	Bevacizumab (Avastin)FDA Link 01/2017 - 10/2007
8	afliberceptIBA 12/2020 - 01/2014
6	Endothelial Growth FactorsIBA 12/2022 - 06/2014
6	Fluorescein (Funduscein)FDA LinkGeneric 02/2016 - 06/2010
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2005
4	Silicone OilsIBA 01/2022 - 05/2008
4	pegaptanib (Macugen)FDA Link 01/2012 - 09/2007
3	Antisense OligonucleotidesIBA 01/2022 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015 - 01/2013
2	Pilocarpine (Ocusert)FDA LinkGeneric 07/2022 - 06/2022
2	taxaneIBA 05/2022 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2017
2	dorzolamide (Trusopt)FDA LinkGeneric 03/2021 - 01/2020
2	Timolol (Blocadren)FDA LinkGeneric 03/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Vancomycin FDA LinkGeneric 01/2021 - 11/2006
2	Indicators and Reagents (Reagents)IBA 05/2020 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 05/2006
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 06/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 04/2015
1	DiamondIBA 10/2022
1	DDMSIBA 10/2022
1	Niacin (Nicotinic Acid)FDA LinkGeneric 05/2022
1	AntigensIBA 11/2021
1	Phosphotransferases (Kinase)IBA 05/2021
1	Axitinib (AG 013736)IBA 05/2021
1	CoagulantsIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	perfluorooctaneIBA 01/2019
1	Anesthetics (Anesthetic Agents)IBA 01/2018
1	Endothelin Receptor AntagonistsIBA 12/2017

Therapy/Procedure

35	Therapeutics 12/2022 - 01/2012
21	Injections 12/2022 - 01/2004
18	Vitrectomy 10/2022 - 11/2006
6	Intravitreal Injections 01/2021 - 03/2009
5	Lasers (Laser) 01/2020 - 01/2004
4	Photochemotherapy (Photodynamic Therapy) 01/2020 - 01/2006
4	Visual Prosthesis 10/2016 - 04/2012
3	Cataract Extraction 09/2020 - 06/2005
3	Light Coagulation 01/2018 - 11/2006
2	Traction 05/2022 - 09/2009
2	Aftercare (After-Treatment) 01/2021 - 03/2017
2	Vitreoretinal Surgery 01/2021 - 09/2017
2	Corneal Transplantation (Keratoplasty) 11/2019 - 01/2019
2	Intraocular Lenses (Intraocular Lens) 01/2018 - 06/2005
2	Prostheses and Implants (Prosthesis) 03/2017 - 10/2015
2	Drug Therapy (Chemotherapy) 10/2012 - 10/2008
2	Intraocular Injections 08/2011 - 01/2004
1	Phacoemulsification 01/2022
1	Scleral Buckling 01/2022
1	Operative Time 01/2019
1	Penetrating Keratoplasty 01/2019
1	Electrodes (Electrode) 01/2018